Avril Dieser
Förmögenhet: 10 700 $ per 2026-05-31
Förmögenhet: 10 700 $ per 2026-05-31
Avril McKean Dieser is an Independent Non-Executive Director at OS Therapies, Inc. since 2024.
Ms. Dieser is Vice President & Head-Legal Patient Evidence at UCB, Inc. since 2016.
Ms. Dieser was a Member at AbbVie, Inc. from 2013 to 2016.
Ms. Dieser completed graduate degrees at the University of Maryland and Columbus School of Law, and an undergraduate degree at Duquesne University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-01-22 | 5 000 ( 0,01 % ) | 10 700 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| OS THERAPIES INCORPORATED | Direktör/Styrelseledamot | 2024-10-28 |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Företagsledare/Principal | 2016-08-01 |
| Företag | Position | Slut |
|---|---|---|
| ABBVIE INC. | Företagsledare/Principal | 2016-07-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Columbus School of Law
Columbus School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OS Therapies, Inc.
OS Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical stage therapeutic company engages in development and commercialization of treatments for osteosarcoma | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån